PanoramicaGraficoNotizieSchermataTrader

Soc. Generale Knock-Out VRTX/  DE000SW9WHJ2  /

Frankfurt Zert./SG
12/11/2024  21:44:26 Var.-0.980 Denaro21:59:19 Lettera21:59:19 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
10.730EUR -8.37% 10.630
Quantità in denaro: 1,000		 10.740
Quantità in lettera: 1,000		 Vertex Pharmaceutica... 376.7216 USD 31/12/2078 Call
GlobeNewswire 13/08 Entrada Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire 09/08 ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 07/08 Editas Medicine Announces Second Quarter 2024 Results and Business Updates
GlobeNewswire 05/08 Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
GlobeNewswire 05/08 CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Newsfile Corp 17/07 Analysts Hunt for Undervalued Biotech Stocks
Newsfile Corp 11/07 Biopharma Stocks Transformative Innovation for the Future of Health
GlobeNewswire 09/07 Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management
GlobeNewswire 09/07 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire 28/06 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire 10/06 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire 29/05 CRISPR Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 23/05 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 15/05 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 09/05 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire 08/05 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 08/05 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire 08/05 Editas Medicine Announces First Quarter 2024 Results and Business Updates
GlobeNewswire 07/05 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 30/04 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire 27/04 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire 25/04 American Kidney Fund Launches National Kidney Health Equity Media Campaign
GlobeNewswire 22/04 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 22/04 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire 22/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN